October 20, 2025

ResMed Inc. (RMD) Stock Analysis: Exploring Growth Potential and Analyst Ratings

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and innovative product offerings. With a market capitalization of..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating a 4.33% Upside Potential with Robust Growth

Thermo Fisher Scientific Inc (NYSE: TMO) continues to solidify its position as a leader in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Emerging Markets find strength in an unlikely alignment

Emerging markets are showing renewed strength as rising gold prices, trade stability and easier policy combine to reshape investor sentiment...

Bristol-Myers Squibb (BMY) Investor Outlook: Navigating a 21.59% Potential Upside Amidst Strong Dividend Yield

Investors looking at Bristol-Myers Squibb Company (NYSE: BMY) are presented with a unique opportunity within the healthcare sector, especially given its recent financial metrics and analyst ratings. With a market..

GSK plc (GSK) Stock Analysis: Analyst Ratings Reveal a Cautious Outlook Amid Solid Dividend Yield

GSK plc (GSK), a titan in the healthcare sector, stands as a prominent player in the drug manufacturing industry with a market capitalization of $88.28 billion. Headquartered in London, this..

Vertex Pharmaceuticals (VRTX) Investor Outlook: Analyzing a 15% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a powerhouse in the biotechnology sector, with a particular focus on transformative therapies for cystic fibrosis (CF). With a robust market capitalization of..

Abbott Laboratories (ABT) Stock Analysis: Evaluating a 12.33% Potential Upside for Investors

Abbott Laboratories (NYSE: ABT) stands as a stalwart in the healthcare sector, particularly in the medical devices industry. With a substantial market capitalization of $223.72 billion, Abbott is a heavy..

A shift in natural‑gas dynamics invites a fresh look at supply constraints

Rising LNG flows and slightly lower U.S. output are tightening the natural‑gas balance...

Galliford Try secures place on The Hyde Group’s £3b affordable homes framework

Galliford Try’s Building division has been appointed to all seven lots of The Hyde Group’s new £3 billion Main Contractor framework, covering the East, South and London regions...

Kainos to host Capital Markets Event in London on 22 October 2025

Kainos, the UK-based IT services and software company, will hold a Capital Markets Event for analysts and institutional investors on 22 October 2025 at Investec’s London offices...

Plus500 reports strong Q3 2025 performance as US futures funds surpass $1 billion

Plus500 delivered steady results for Q3 2025, with revenue of $182.7 million and EBITDA of $82.7 million, maintaining a 45% margin. Customer income rose 8% year-on-year to $536.7 million for..

Sirius Real Estate acquires €43.7m business park near Munich, expanding German portfolio

Sirius Real Estate has completed the €43.7 million acquisition of a 27,180 sqm business park in Feldkirchen, near Munich. The site, 94% occupied and generating €3.4 million in annual rent,..

B&M lowers FY26 outlook following £7m freight cost adjustment and CFO resignation

B&M European Value Retail has revised its FY26 outlook after identifying around £7 million of overseas freight costs that were not correctly recorded due to a system update earlier in..

AstraZeneca Tezspire approved in the US for chronic rhinosinusitis with nasal polyps

The US FDA has approved AstraZeneca and Amgen’s Tezspire (tezepelumab) as an add-on maintenance treatment for patients aged 12 and over with inadequately controlled chronic rhinosinusitis with nasal polyps...

GlobalData expects FY25 revenue in line with market forecasts

GlobalData reports 13.5% revenue growth in Q3 2025, supported by stronger subscription performance and recent acquisitions. The company expects full-year revenue to meet market expectations, with underlying growth in the..

EDX Medical secures up to £4m to accelerate diagnostic product development

EDX Medical has raised up to £4 million to advance its digital diagnostic products for cancer, cardiovascular, and infectious diseases. The funding includes a £2 million share placing at 14p..

Scottish Mortgage Investment T (SMT.L): A Closer Look at the $12.56 Billion Market Cap Opportunity

Scottish Mortgage Investment Trust (SMT.L), a stalwart in the investment trust sector, offers investors a unique opportunity with its substantial market capitalization of $12.56 billion. Despite the absence of traditional..

Taylor Wimpey PLC (TW.L) Investor Outlook: Navigating a High Dividend Yield and Potential 27% Upside

For investors with a keen eye on the residential construction industry, Taylor Wimpey PLC (TW.L) presents a compelling case, especially amidst the current market landscape. Based in the United Kingdom..

Weir Group PLC (WEIR.L) Stock Analysis: A Strong Industry Player with Noteworthy Potential Upside

Weir Group PLC (WEIR.L), a stalwart in the Specialty Industrial Machinery sector, commands a prominent position within the industrials realm. With a market capitalization of $7.38 billion, this UK-based company..

Persimmon PLC (PSN.L) Stock Analysis: Evaluating a 26.57% Potential Upside for Investors

Persimmon PLC (LSE: PSN), a prominent player in the residential construction industry, presents an intriguing proposition for investors navigating the ever-evolving landscape of the UK housing market. With a substantial..

Search

Funds

October 20, 2025

Emerging Markets find strength in an unlikely alignment

Emerging markets are showing renewed strength as rising gold prices, trade stability and easier policy combine to reshape investor sentiment...

A shift in natural‑gas dynamics invites a fresh look at supply constraints

Rising LNG flows and slightly lower U.S. output are tightening the natural‑gas balance...

Galliford Try secures place on The Hyde Group’s £3b affordable homes framework

Galliford Try’s Building division has been appointed to all seven lots of The Hyde Group’s new £3 billion Main Contractor framework, covering the East, South and London regions...

Kainos to host Capital Markets Event in London on 22 October 2025

Kainos, the UK-based IT services and software company, will hold a Capital Markets Event for analysts and institutional investors on 22 October 2025 at Investec’s London offices...

Plus500 reports strong Q3 2025 performance as US futures funds surpass $1 billion

Plus500 delivered steady results for Q3 2025, with revenue of $182.7 million and EBITDA of $82.7 million, maintaining a 45% margin. Customer income rose 8% year-on-year to $536.7 million for the first nine months, supported by growth in higher-value clients and strong US futures performance...

Sirius Real Estate acquires €43.7m business park near Munich, expanding German portfolio

Sirius Real Estate has completed the €43.7 million acquisition of a 27,180 sqm business park in Feldkirchen, near Munich. The site, 94% occupied and generating €3.4 million in annual rent, delivers a 7.8% EPRA Net Initial Yield...

B&M lowers FY26 outlook following £7m freight cost adjustment and CFO resignation

B&M European Value Retail has revised its FY26 outlook after identifying around £7 million of overseas freight costs that were not correctly recorded due to a system update earlier in the year...

AstraZeneca Tezspire approved in the US for chronic rhinosinusitis with nasal polyps

The US FDA has approved AstraZeneca and Amgen’s Tezspire (tezepelumab) as an add-on maintenance treatment for patients aged 12 and over with inadequately controlled chronic rhinosinusitis with nasal polyps...

GlobalData expects FY25 revenue in line with market forecasts

GlobalData reports 13.5% revenue growth in Q3 2025, supported by stronger subscription performance and recent acquisitions. The company expects full-year revenue to meet market expectations, with underlying growth in the low single digits..

EDX Medical secures up to £4m to accelerate diagnostic product development

EDX Medical has raised up to £4 million to advance its digital diagnostic products for cancer, cardiovascular, and infectious diseases. The funding includes a £2 million share placing at 14p per share and a £2 million convertible loan note from founder Professor Sir Chris Evans...
Search

Funds

October 20, 2025

FTSE 100

Funds